| Dr Nabil Charles Chehade, MD | |
|
2500 Metrohealth Dr, Cleveland, OH 44109-1900 | |
| (216) 778-7800 | |
| Not Available |
| Full Name | Dr Nabil Charles Chehade |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 32 Years |
| Location | 2500 Metrohealth Dr, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255445789 | NPI | - | NPPES |
| 2137913 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 35-074133 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Metrohealth System | 8628982949 | 1026 |
News Archive
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).
New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.
Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of Enhancing Autoimmunity," appears in the December 2009 issue of The American Journal of Pathology.
Huntington's disease (HD) is a cruel, hereditary condition that leads to severe physical and mental deterioration, psychiatric problems and eventually, death. Currently, there are no treatments to slow down or stop it. HD sufferers are born with the disease although they do not show symptoms until late in life.
› Verified 4 days ago
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).
New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.
Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of Enhancing Autoimmunity," appears in the December 2009 issue of The American Journal of Pathology.
Huntington's disease (HD) is a cruel, hereditary condition that leads to severe physical and mental deterioration, psychiatric problems and eventually, death. Currently, there are no treatments to slow down or stop it. HD sufferers are born with the disease although they do not show symptoms until late in life.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nabil Charles Chehade, MD 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 479-5541 | Dr Nabil Charles Chehade, MD 2500 Metrohealth Dr, Cleveland, OH 44109-1900 Ph: (216) 778-7800 |
News Archive
The prognosis for people with hepatitis C has improved dramatically in the last few years, thanks to the introduction of direct-acting anti-viral medications, including Harvoni (the brand name for a combination of ledipasvir and sofosbuvir) and Viekira Pack (a mix of ombitasvir, paritaprevir, ritonavir and dasabuvir).
New findings about a temperature sensor in the skin could lead to novel approaches to controlling excess hair growth and treating skin cancers.
Current research suggests that a common oral bacterium may exacerbate autoimmune disease. The related report by Nichols et al, "Unique Lipids from a Common Human Bacterium Represent a New Class of TLR2 Ligands Capable of Enhancing Autoimmunity," appears in the December 2009 issue of The American Journal of Pathology.
Huntington's disease (HD) is a cruel, hereditary condition that leads to severe physical and mental deterioration, psychiatric problems and eventually, death. Currently, there are no treatments to slow down or stop it. HD sufferers are born with the disease although they do not show symptoms until late in life.
› Verified 4 days ago
Andrew Wood, Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 616-706-9286 | |
Dr. Michael T Berte, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6900 Pearl Rd, 2nd Floor, Cleveland, OH 44130 Phone: 440-845-0900 Fax: 440-845-7355 | |
William E Forsythe Iii, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Dr. Irina Jaeger, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-3009 | |
Rajan Ramanathan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2000 | |
Dr. Jason Thomas Jankowski, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 440-617-4726 | |
Petar Bajic, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q10-1, Cleveland, OH 44195 Phone: 216-444-1231 |